3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of Cod Residual Protein Supplementation on Markers of Glucose Regulation in Lean Adults: A Randomized Double-Blind Study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Large quantities of protein-rich cod residuals, which are currently discarded, could be utilized for human consumption. Although fish fillet intake is related to beneficial health effects, little is known about the potential health effects of consuming cod residual protein powder. Fifty lean adults were randomized to consume capsules with 8.1 g/day of cod residual protein (Cod-RP) or placebo capsules (Control group) for eight weeks, in this randomized, double-blind study. The intervention was completed by 40 participants. Fasting glucose and insulin concentrations were unaffected by Cod-RP supplementation, whereas plasma concentrations of α-hydroxybutyrate, β-hydroxybutyrate and acetoacetate all were decreased compared with the Control group. Trimethylamine N-oxide concentration in plasma and urine were increased in the Cod-RP group compared with the Control group. To conclude, the reduction in these potential early markers of impaired glucose metabolism following Cod-RP supplementation may indicate beneficial glucoregulatory effects of cod residual proteins. Trimethylamine N-oxide appears to be an appropriate biomarker of cod residual protein intake in lean adults.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study.

          This paper describes the Observing Protein and Energy Nutrition (OPEN) Study, conducted from September 1999 to March 2000. The purpose of the study was to assess dietary measurement error using two self-reported dietary instruments-the food frequency questionnaire (FFQ) and the 24-hour dietary recall (24HR)-and unbiased biomarkers of energy and protein intakes: doubly labeled water and urinary nitrogen. Participants were 484 men and women aged 40-69 years from Montgomery County, Maryland. Nine percent of men and 7% of women were defined as underreporters of both energy and protein intake on 24HRs; for FFQs, the comparable values were 35% for men and 23% for women. On average, men underreported energy intake compared with total energy expenditure by 12-14% on 24HRs and 31-36% on FFQs and underreported protein intake compared with a protein biomarker by 11-12% on 24HRs and 30-34% on FFQs. Women underreported energy intake on 24HRs by 16-20% and on FFQs by 34-38% and underreported protein intake by 11-15% on 24HRs and 27-32% on FFQs. There was little underreporting of the percentage of energy from protein for men or women. These findings have important implications for nutritional epidemiology and dietary surveillance.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.

            Trimethylamine N-oxide (TMAO) is a biologically active molecule and is a putative promoter of chronic diseases including atherosclerosis in humans. Host intestinal bacteria produce its precursor trimethylamine (TMA) from carnitine, choline, or choline-containing compounds. Most of the TMA produced is passively absorbed into portal circulation, and hepatic flavin-dependent monooxygenases (FMOs) efficiently oxidize TMA to TMAO. Both observational and experimental studies suggest a strong positive correlation between increased plasma TMAO concentrations and adverse cardiovascular events, such as myocardial infarction, stroke, and death. However, a clear mechanistic link between TMAO and such diseases is not yet validated. Therefore, it is debated whether increased TMAO concentrations are the cause or result of these diseases. Here, we have tried to review the current understanding of the properties and physiological functions of TMAO, its dietary sources, and its effects on human metabolism. Studies that describe the potential role of TMAO in the etiology of cardiovascular and other diseases are also discussed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial.

              Trimethylamine-N-oxide (TMAO), a metabolite linked to the gut microbiota, is associated with excess risk of heart disease. We hypothesized that (i) TMAO response to animal source foods would vary among healthy men and (ii) this response would be modified by their gut microbiome.
                Bookmark

                Author and article information

                Journal
                Nutrients
                Nutrients
                nutrients
                Nutrients
                MDPI
                2072-6643
                16 May 2020
                May 2020
                : 12
                : 5
                : 1445
                Affiliations
                [1 ]Dietary Protein Research Group, Department of Clinical Medicine, University of Bergen, 5021 Bergen, Norway; nkjgu@ 123456uib.no
                [2 ]K. Halstensen AS, P.O. Box 103, 5399 Bekkjarvik, Norway; alfred.halstensen@ 123456uib.no
                [3 ]Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
                [4 ]Bevital AS, Jonas Lies veg 87, 5021 Bergen, Norway; adrian.mccann@ 123456bevital.no (A.M.); nkjbm@ 123456uib.no (Ø.M.); per.ueland@ 123456ikb.uib.no (P.M.U.)
                [5 ]Nofima, P.B. 1425 Oasen, 5844 Bergen, Norway; aage.oterhals@ 123456nofima.no
                Author notes
                [* ]Correspondence: iselin.vildmyren@ 123456uib.no ; Tel.: +47-5597-5553
                Author information
                https://orcid.org/0000-0002-5728-5321
                https://orcid.org/0000-0002-5378-4131
                https://orcid.org/0000-0001-5268-692X
                Article
                nutrients-12-01445
                10.3390/nu12051445
                7285039
                32429429
                84d89e4f-b5ab-4ef7-a895-b391bfd557a3
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 16 April 2020
                : 13 May 2020
                Categories
                Article

                Nutrition & Dietetics
                dietary supplements,fish protein,marine protein,hydroxybutyrate,tmao,biomarkers
                Nutrition & Dietetics
                dietary supplements, fish protein, marine protein, hydroxybutyrate, tmao, biomarkers

                Comments

                Comment on this article